Table 8.

Pseudoptosis: Reported Incidence and Management

No of respondents (%)
What percentage of patients in your practice present with pseudoptosis (ie, lack of pretarsal show due to severe dermatochalasis—refer to Figure 2)?
 ≤10%7 (3.3%)
 11%-25%33 (15.4%)
 26%-50%71 (33.2%)
 515-75%72 (33.6%)
 >75%31 (14.5%)
Do you modify your upper blepharoplasty technique in patients who lack pretarsal show (ie, pseudoptosis)? (Select all that apply)
 No change in technique61 (28.5%)
 Decrease the amount of skin resection (compared with patients without pseudoptosis)5 (2.3%)
 Increase the amount of skin resection (compared with patients without pseudoptosis)121 (56.5%)
 Orbital fat preservation (remove less or no orbital fat when compared with your technique used for patients without pseudoptosis)23 (10.8%)
 Remove more orbital fat (when compared with your technique used for patients without pseudoptosis)52 (24.3%)
 Orbicularis muscle preservation (when compared with your technique used for patients without pseudoptosis)16 (7.5%)
 More orbicularis muscle removal (when compared with your technique used for patients without pseudoptosis)46 (21.5%)
 Other13 (6.1%)
No of respondents (%)
What percentage of patients in your practice present with pseudoptosis (ie, lack of pretarsal show due to severe dermatochalasis—refer to Figure 2)?
 ≤10%7 (3.3%)
 11%-25%33 (15.4%)
 26%-50%71 (33.2%)
 515-75%72 (33.6%)
 >75%31 (14.5%)
Do you modify your upper blepharoplasty technique in patients who lack pretarsal show (ie, pseudoptosis)? (Select all that apply)
 No change in technique61 (28.5%)
 Decrease the amount of skin resection (compared with patients without pseudoptosis)5 (2.3%)
 Increase the amount of skin resection (compared with patients without pseudoptosis)121 (56.5%)
 Orbital fat preservation (remove less or no orbital fat when compared with your technique used for patients without pseudoptosis)23 (10.8%)
 Remove more orbital fat (when compared with your technique used for patients without pseudoptosis)52 (24.3%)
 Orbicularis muscle preservation (when compared with your technique used for patients without pseudoptosis)16 (7.5%)
 More orbicularis muscle removal (when compared with your technique used for patients without pseudoptosis)46 (21.5%)
 Other13 (6.1%)

Skipped questions were excluded from total answer counts.

Table 8.

Pseudoptosis: Reported Incidence and Management

No of respondents (%)
What percentage of patients in your practice present with pseudoptosis (ie, lack of pretarsal show due to severe dermatochalasis—refer to Figure 2)?
 ≤10%7 (3.3%)
 11%-25%33 (15.4%)
 26%-50%71 (33.2%)
 515-75%72 (33.6%)
 >75%31 (14.5%)
Do you modify your upper blepharoplasty technique in patients who lack pretarsal show (ie, pseudoptosis)? (Select all that apply)
 No change in technique61 (28.5%)
 Decrease the amount of skin resection (compared with patients without pseudoptosis)5 (2.3%)
 Increase the amount of skin resection (compared with patients without pseudoptosis)121 (56.5%)
 Orbital fat preservation (remove less or no orbital fat when compared with your technique used for patients without pseudoptosis)23 (10.8%)
 Remove more orbital fat (when compared with your technique used for patients without pseudoptosis)52 (24.3%)
 Orbicularis muscle preservation (when compared with your technique used for patients without pseudoptosis)16 (7.5%)
 More orbicularis muscle removal (when compared with your technique used for patients without pseudoptosis)46 (21.5%)
 Other13 (6.1%)
No of respondents (%)
What percentage of patients in your practice present with pseudoptosis (ie, lack of pretarsal show due to severe dermatochalasis—refer to Figure 2)?
 ≤10%7 (3.3%)
 11%-25%33 (15.4%)
 26%-50%71 (33.2%)
 515-75%72 (33.6%)
 >75%31 (14.5%)
Do you modify your upper blepharoplasty technique in patients who lack pretarsal show (ie, pseudoptosis)? (Select all that apply)
 No change in technique61 (28.5%)
 Decrease the amount of skin resection (compared with patients without pseudoptosis)5 (2.3%)
 Increase the amount of skin resection (compared with patients without pseudoptosis)121 (56.5%)
 Orbital fat preservation (remove less or no orbital fat when compared with your technique used for patients without pseudoptosis)23 (10.8%)
 Remove more orbital fat (when compared with your technique used for patients without pseudoptosis)52 (24.3%)
 Orbicularis muscle preservation (when compared with your technique used for patients without pseudoptosis)16 (7.5%)
 More orbicularis muscle removal (when compared with your technique used for patients without pseudoptosis)46 (21.5%)
 Other13 (6.1%)

Skipped questions were excluded from total answer counts.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close